You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 7, July 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  Short Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bullous Pemphigoid

Clinical and Serologic Evaluation for Associated Malignant Neoplasms

A. Razzaque Ahmed, MD; T. Ming Chu, PhD; Thomas T. Provost, MD

Arch Dermatol. 1977;113(7):969.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Bullous pemphigoid (BP) has been reported in association with malignant neoplasms of the urinary tract, lung, genitalia, breast, pancreas, gastrointestinal (GI) tract, skin, and lymphoreticular system.1 The course of BP usually does not parallel the course of the malignant neoplasm. The malignant neoplasm may be evident at the onset of BP or present as an incidental finding at postmortem examination.2

Carcinoembryonic antigen (CEA) levels greater than 2.5 ng/ml have been reported in serum samples from patients with pancreatic, colonic, rectal, gastric, mammary, and cervical malignant neoplasms, and in some leukemias.3 The presence of CEA correlates with a high incidence of proved malignant neoplasms and is an early indicator of clinically unrecognized recurrence.4

The purpose of this study was to determine the incidence of a malignant neoplasm in a large number of patients with BP using clinical as well as serologic evaluation.

Subjects and Methods

Thirty-three patients . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Dermatology, State University of New York at Buffalo School of Medicine (Drs Ahmed and Provost), and Diagnostic Immunology, Roswell Park Memorial Institute (Dr Chu), Buffalo. Dr Ahmed is now with the University of California at Los Angeles School of Medicine.


Footnotes

Reprint requests to Department of Dermatology, State University of New York at Buffalo School of Medicine, 50 High St, Buffalo, NY 14203 (Dr Provost).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.